Many of them have health conditions, and tell us overwhelmingly that their primary motivation for weight loss is around improving their health, and helping to prevent future health problems, she tells me
Regulatory Approvals/Commercial Semaglutide is a GLP-1 analog, developed in 2012 by Novo Nordisk, as a longer acting alternative to liraglutide
Pancreatitis Pancreatitis, or inflammation of the pancreas, is a potentially life-threatening condition that has been linked to GLP-1 receptor agonists like Ozempic
From initial consultation to ongoing support, were here to help you make steady progress, adjust when needed, and stay focused on results that last
Review medications and supplements with your clinician if you bruise more than expected